Natroba spinosad regulatory update

FDA approved an NDA from SePRO's ParaPRO LLC subsidiary for Natroba spinosad topical 0.9% to treat head lice in patients >=4 years of age. Earlier this month, ParaPRO partnered with Pernix Therapeuti...